DUBLIN, Calif., May 7 /PRNewswire/ -- Microchip Biotechnologies, a private company developing the Apollo next-generation fluidics platform for life sciences, announced today that Andre F. Marion has accepted a board position to its Board of Directors, effective immediately. Mr. Marion was former CEO of Applied Biosystems and today serves on the boards of several venture capital backed companies.
"Andre Marion brings an immense depth of global commercial and operational experience in the life science tools market to Microchip Biotechnologies' Board of Directors. His leadership of Applied Biosystems and experience on other Boards will greatly assist the stewardship of our company," said Dr. Stevan Jovanovich, President and CEO of Microchip Biotechnologies.
"I believe that the simplicity, flexibility and potential for low cost manufacturing offered by Microchip Biotechnologies' Apollo platform are particularly well suited for the design of integrated systems that can accelerate the collection, preparation and analysis of biological samples," said Mr. Marion. "A wide variety of applications in life science research, diagnostics, and environmental fields, that require robustness and reliability, are obvious candidates for the platform."
Andre F. Marion was a co-founder of Applied Biosystems; Applied Biosystems was acquired by Invitrogen in 2008 to form Life Technologies. At Applied Biosystems Mr. Marion held a series of pivotal positions. He initially held the post of Vice President of Engineering in 1981 and became Chief Operating Officer in 1983. In 1986 Mr. Marion was promoted to President and Chief Executive Officer of Applied Biosystems and also held the position of Chairman of the Board from 1987 until 1993 when Applied Biosystems merged with Perkin Elmer. Andre F. Marion retired from Perkin Elmer Corporation as President of the Applied Biosystems Division in 1993. Prior to founding Applied Biosystems, he held various Research and Development managerial positions at Hewlett-Packard.
As a native of France, Mr. Andre F. Marion holds an engineering degree from the French Ecole Nationale Superieures d'Ingenieurs Arts et Metiers in both mechanical and electronic engineering.
About Microchip Biotechnologies
Microchip Biotechnologies, Inc., (MBI), is a privately-held company located in Dublin, California. The company is developing the Apollo next-generation fluidics platform for life sciences, applied sciences, and diagnostics markets. The Apollo platform integrates advanced microfluidic sample preparation, and analytical capabilities, to produce sample-to-answer performance for DNA sequencing, biodefense, DNA-based forensics and human identity (HID), and molecular diagnostics applications. The platform incorporates MBI's proprietary BeadStorm(TM) bead-based sample preparation devices and 'Microscale On-Chip Valve' (MOVe(TM)) valves, pumps, and routers on microchips. More details about MBI, its technologies and products can be found at: www.microchipbiotech.com
|SOURCE Microchip Biotechnologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved